Literature DB >> 28705468

Association of anti-inflammatory cytokine IL10 polymorphisms with motoric cognitive risk syndrome in an Ashkenazi Jewish population.

Sanish Sathyan1, Nir Barzilai2, Gil Atzmon3, Sofiya Milman2, Emmeline Ayers1, Joe Verghese4.   

Abstract

Motoric cognitive risk (MCR) syndrome is a newly described predementia syndrome characterized by the presence of cognitive complaints and slow gait, which is associated with increased risk of conversion to dementia. The underlying biological mechanisms for MCR have not yet been established. Neuroinflammation mediated through cytokines plays a pivotal role in the pathogenesis of dementia. Hence, our objective was to prospectively examine whether variations in cytokine genes (CRP, IFNG, IL1A, IL1B, IL4, IL6, IL10, IL18, TNF, and IL12A) play a role in MCR incidence in 530 community-dwelling Ashkenazi Jewish adults aged 65 years and older without MCR or dementia at baseline enrolled in the LonGenity study. Over a median follow-up of 2.99 years, 70 participants developed MCR. Single nucleotide polymorphisms (SNPs) in the transcriptional regulatory regions of cytokine IL10, rs1800896 (hazard ratio adjusted for age, gender, and education, aHR: 1.667; 95% CI: 1.198-2.321) and rs3024498 (aHR: 1.926; 95% CI: 1.315-2.822), were associated with incident MCR. Functional analysis using in silico approaches indicated associated SNP rs3024498 "C" allele being the local expression quantitative trait locus. Associated alleles of both the SNPs, rs1800896 and rs3024498, were implicated with overexpression of IL10 gene. None of the variants in the neuroinflammatory pathway studied were associated with incident mild cognitive impairment syndrome. These observations support a role for the IL10 gene in dementia pathogenesis by increasing risk of developing MCR in older adults.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cognition; Dementia; Epidemiological study; Genetics; Inflammation; Mild cognitive impairment syndrome

Mesh:

Substances:

Year:  2017        PMID: 28705468      PMCID: PMC5581722          DOI: 10.1016/j.neurobiolaging.2017.06.006

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  58 in total

1.  SNPStats: a web tool for the analysis of association studies.

Authors:  Xavier Solé; Elisabet Guinó; Joan Valls; Raquel Iniesta; Víctor Moreno
Journal:  Bioinformatics       Date:  2006-05-23       Impact factor: 6.937

2.  IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior.

Authors:  Paramita Chakrabarty; Andrew Li; Carolina Ceballos-Diaz; James A Eddy; Cory C Funk; Brenda Moore; Nadia DiNunno; Awilda M Rosario; Pedro E Cruz; Christophe Verbeeck; Amanda Sacino; Sarah Nix; Christopher Janus; Nathan D Price; Pritam Das; Todd E Golde
Journal:  Neuron       Date:  2015-01-22       Impact factor: 17.173

Review 3.  Evidence for a cytokine model of cognitive function.

Authors:  J McAfoose; B T Baune
Journal:  Neurosci Biobehav Rev       Date:  2008-10-18       Impact factor: 8.989

4.  Intereleukin-10 promoter polymorphism in mild cognitive impairment and in its clinical evolution.

Authors:  Beatrice Arosio; Luigina Mastronardi; Carlo Vergani; Giorgio Annoni
Journal:  Int J Alzheimers Dis       Date:  2010-07-20

5.  Motoric cognitive risk syndrome and the risk of dementia.

Authors:  Joe Verghese; Cuiling Wang; Richard B Lipton; Roee Holtzer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-09-17       Impact factor: 6.053

6.  The reliability and validity of measures of gait variability in community-dwelling older adults.

Authors:  Jennifer S Brach; Subashan Perera; Stephanie Studenski; Anne B Newman
Journal:  Arch Phys Med Rehabil       Date:  2008-12       Impact factor: 3.966

Review 7.  Association between interleukin-10 polymorphisms and Alzheimer's disease: a systematic review and meta-analysis.

Authors:  Danilo Di Bona; Claudia Rizzo; Giuseppe Bonaventura; Giuseppina Candore; Calogero Caruso
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 8.  Neuroinflammation in Alzheimer's disease.

Authors:  Michael T Heneka; Monica J Carson; Joseph El Khoury; Gary E Landreth; Frederic Brosseron; Douglas L Feinstein; Andreas H Jacobs; Tony Wyss-Coray; Javier Vitorica; Richard M Ransohoff; Karl Herrup; Sally A Frautschy; Bente Finsen; Guy C Brown; Alexei Verkhratsky; Koji Yamanaka; Jari Koistinaho; Eicke Latz; Annett Halle; Gabor C Petzold; Terrence Town; Dave Morgan; Mari L Shinohara; V Hugh Perry; Clive Holmes; Nicolas G Bazan; David J Brooks; Stéphane Hunot; Bertrand Joseph; Nikolaus Deigendesch; Olga Garaschuk; Erik Boddeke; Charles A Dinarello; John C Breitner; Greg M Cole; Douglas T Golenbock; Markus P Kummer
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

9.  The dynamics of monocytes and microglia in Alzheimer's disease.

Authors:  Peter Thériault; Ayman ElAli; Serge Rivest
Journal:  Alzheimers Res Ther       Date:  2015-04-15       Impact factor: 6.982

10.  Genetic variability in the regulation of gene expression in ten regions of the human brain.

Authors:  Adaikalavan Ramasamy; Daniah Trabzuni; Sebastian Guelfi; Vibin Varghese; Colin Smith; Robert Walker; Tisham De; Lachlan Coin; Rohan de Silva; Mark R Cookson; Andrew B Singleton; John Hardy; Mina Ryten; Michael E Weale
Journal:  Nat Neurosci       Date:  2014-08-31       Impact factor: 24.884

View more
  8 in total

1.  Frailty and Risk of Incident Motoric Cognitive Risk Syndrome.

Authors:  Sanish Sathyan; Emmeline Ayers; Tina Gao; Sofiya Milman; Nir Barzilai; Kenneth Rockwood; Joe Verghese
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 2.  Motoric cognitive risk syndrome: Integration of two early harbingers of dementia in older adults.

Authors:  Richard D Semba; Qu Tian; Michelle C Carlson; Qian-Li Xue; Luigi Ferrucci
Journal:  Ageing Res Rev       Date:  2020-01-26       Impact factor: 10.895

3.  Motoric cognitive risk syndrome in people with multiple sclerosis: prevalence and correlations with disease-related factors.

Authors:  Sapir Dreyer-Alster; Shay Menascu; Roy Aloni; Uri Givon; Mark Dolev; Anat Achiron; Alon Kalron
Journal:  Ther Adv Neurol Disord       Date:  2022-07-04       Impact factor: 6.430

4.  Genetic basis of motoric cognitive risk syndrome in the Health and Retirement Study.

Authors:  Sanish Sathyan; Tao Wang; Emmeline Ayers; Joe Verghese
Journal:  Neurology       Date:  2019-02-08       Impact factor: 9.910

5.  Cortical Thickness, Volume, and Surface Area in the Motoric Cognitive Risk Syndrome.

Authors:  Helena M Blumen; Emily Schwartz; Gilles Allali; Olivier Beauchet; Michele Callisaya; Takehiko Doi; Hiroyuki Shimada; Velandai Srikanth; Joe Verghese
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

6.  An Immunological Perspective to Non-syndromic Sensorineural Hearing Loss.

Authors:  K P Sindura; Moinak Banerjee
Journal:  Front Immunol       Date:  2019-12-11       Impact factor: 7.561

Review 7.  Motoric Cognitive Risk Syndrome: Symptoms, Pathology, Diagnosis, and Recovery.

Authors:  Ke Xiang; Yin Liu; Li Sun
Journal:  Front Aging Neurosci       Date:  2022-02-02       Impact factor: 5.750

8.  Sarcopenia and motoric cognitive risk syndrome: a moderated mediation model.

Authors:  Ting Zhang; Yunyun Zhang; Ziyan Lv; Jie Xiang
Journal:  BMC Geriatr       Date:  2022-02-19       Impact factor: 3.921

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.